Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma kallikrein-kinin system

American Journal of Pathology

Volumn 171, Issue 1, 2007, Pages 349-360

  Astern, Joshua M ^a   Pendergraft III, William F ^a   Falk, Ronald J ^a   Jennette, J Charles ^a   Schmaier, Alvin H ^b,c   Mahdi, Fakhri ^a   Preston, Gloria A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CYTOKERATIN 1; MYELOPEROXIDASE; CARRIER PROTEIN; CYTOKERATIN 9; HIGH MOLECULAR WEIGHT KININOGEN; PEROXIDASE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTERNALIZATION; KALLIKREIN KININ SYSTEM; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; BIOSYNTHESIS; CELL CULTURE; CELL MEMBRANE; MACROMOLECULE; METABOLISM; PHYSIOLOGY; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

BRADYKININ; CARRIER PROTEINS; CELL MEMBRANE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; KALLIKREIN-KININ SYSTEM; KERATIN-1; KERATIN-9; KININOGEN, HIGH-MOLECULAR-WEIGHT; MACROMOLECULAR SUBSTANCES; PEROXIDASE;

EID: 34547693434     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060831     Document Type: Article

References (42)

1. Nauseef WM, Malech HL: Analysis of the peptide subunits of human neutrophil myeloperoxidase. Blood 1986, 67:1504-1507
2. Pullar JM, Vissers MC, Winterbourn CC: Living with a killer: the effects of hypochlorous acid on mammalian cells. IUBMB Life 2000, 50:259-266
3. Arimura Y, Minoshima S, Kamiya Y, Tanaka U, Nakabayashi K, Kitamoto K, Nagasawa T, Sasaki T, Suzuki K: Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol 1993, 40:256-264
4. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, Simoons ML, Hamm CW: Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003, 108:1440-1445
5. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL: Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003, 349:1595-1604
6. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL: Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001, 286:2136-2142
7. Kalantar-Zadeh K, Brennan ML, Hazen SL: Serum myeloperoxidase and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2006, 48:59-68
8. Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, Freeman BA: Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002, 296:2391-2394
9. Zhang C, Patel R, Eiserich JP, Zhou F, Kelpke S, Ma W, Parks DA, Darley-Usmar V, White CR: Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid. Am J Physiol 2001, 281:H1469-H1475
10. Baldus S, Heitzer T, Eiserich JP, Lau D, Mollnau H, Ortak M, Petri S, Goldmann B, Duchstein HJ, Berger J, Helmchen U, Freeman BA, Meinertz T, Munzel T: Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 2004, 37:902-911
11. Yang JJ, Preston GA, Pendergraft WF, Segelmark M, Heeringa P, Hogan SL, Jennette JC, Falk RJ: Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol 2001, 158:581-592
12. Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P, Ma W, Tousson A, White CR, Bullard DC, Brennan ML, Lusis AJ, Moore KP, Freeman BA: Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 2001, 108:1759-1770
13. Joseph K, Tholanikunnel BG, Ghebrehiwet B, Kaplan AP: Interaction of high molecular weight kininogen binding proteins on endothelial cells. Thromb Haemost 2004, 91:61-70
14. Mahdi F, Shariat-Madar Z, Todd III RF, Figueroa CD, Schmaier AH: Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood 2001, 97:2342-2350
15. Shariat-Madar Z, Mahdi F, Schmaier AH: Recombinant prolylcarboxypeptidase activates plasma prekallikrein. Blood 2004, 103:4554-4561
16. Hasan AA, Zisman T, Schmaier AH: Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc Natl Acad Sci USA 1998, 95:3615-3620
17. Shariat-Madar Z, Mahdi F, Schmaier AH: Mapping binding domains of kininogens on endothelial cell cytokeratin 1. J Biol Chem 1999, 274:7137-7145
18. Parker CE, Warren MR, Loiselle DR, Dicheva NN, Borchers CH: Identification of components of protein complexes. Methods in Molecular Biology, Ubiquitin-Proteasome Protocols. Edited by C Patterson and DM Cyr. Totowa, Humana Press, 2005, pp 117-171
19. Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988, 318:1651-1657
20. Segelmark M, Persson B, Hellmark T, Wieslander J: Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? Clin Exp Immunol 1997, 108:167-174
21. Tiruppathi C, Naqvi T, Wu Y, Vogel SM, Minshall RD, Malik AB: Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells. Proc Natl Acad Sci USA 2004, 101:7699-7704
22. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, Hazen SL: Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004, 114:529-541
23. Zhao Y, Qiu Q, Mahdi F, Shariat-Madar Z, Rojkjaer R, Schmaier AH: Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation. Am J Physiol 2001, 280:H1821-H1829
24. Kozik A, Moore RB, Potempa J, Imamura T, Rapala-Kozik M, Travis J: A novel mechanism for bradykinin production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens. J Biol Chem 1998, 273:33224-33229
25. Nieziołek M, Kot M, Pyka K, Mak P, Kozik A: Properties of chemically oxidized kininogens. Acta Biochim Pol 2003, 50:753-763
26. Khor HK, Fisher MT, Schoneich C: Potential role of methionine sulfoxide in the inactivation of the chaperone GroEL by hypochlorous acid (HOCl) and peroxynitrite (ONOO-). J Biol Chem 2004, 279:19486-19493
27. Fu X, Kassim SY, Parks WC, Heinecke JW: Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J Biol Chem 2003, 278:28403-28409
28. Collard CD, Montalto MC, Reenstra WR, Buras JA, Stahl GL: Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol 2001, 159:1045-1054
29. Hasan AA, Cines DB, Ngaiza JR, Jaffe EA, Schmaier AH: High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium. Blood 1995, 85:3134-3143
30. Shariat-Madar Z, Schmaier AH: Kininogen-cytokeratin 1 interactions in endothelial cell biology. Trends Cardiovasc Med 1999, 9:238-244
31. Johansson MW, Patarroyo M, Oberg F, Siegbahn A, Nilsson K: Myeloperoxidase mediates cell adhesion via the alpha M beta 2 integrin (Mac-1, CD11b/CD18). J Cell Sci 1997, 110:1133-1139
32. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM, Brummer J, Rudolph V, Munzel T, Heitzer T, Meinertz T, Baldus S: Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci USA 2005, 102:431-436
33. Sheng N, Fairbanks MB, Heinrikson RL, Canziani G, Chaiken IM, Mosser DM, Zhang H, Colman RW: Cleaved high molecular weight kininogen binds directly to the integrin CD11b/CD18 (Mac-1) and blocks adhesion to fibrinogen and ICAM-1. Blood 2000, 95:3788-3795
34. Brown NJ, Gainer JV, Murphey LJ, Vaughan DE: Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation 2000, 102:2190-2196
35. Marceau F, Regoli D: Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 2004, 3:845-852
36. Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P: Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 2004, 24:1309-1314
37. Bergt C, Pennathur S, Fu X, Byun J, O'Brien K, McDonald TO, Singh P, Anantharamaiah GM, Chait A, Brunzell J, Geary RL, Oram JF, Heinecke JW: The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci USA 2004, 101:13032-13037
38. Nauseef WM: Insights into myeloperoxidase biosynthesis from its inherited deficiency. J Mol Med 1998, 76:661-668
39. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HM, Ischiropoulos H, Hazen SL: A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 2002, 277:17415-17427
40. Mohiuddin I, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C: Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res 2006, 133:143-149
41. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998, 391:393-397
42. Baldus S, Eiserich JP, Brennan ML, Jackson RM, Alexander CB, Freeman BA: Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radic Biol Med 2002, 33:1010-1019